Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine for vasopressor requirement in septic shock
TCTR20180310001Phase 1Terminated
- Sponsor
- The King's Fund
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of thiamine in septic shock (2 arms), sponsored by The King's Fund. Primary endpoint: Vasopressor-free days. Started Mar 2018; status: terminated.
02
Drugs
thiamine
03
Conditions
septic shock
Beyond the preview
Go deeper on TCTR20180310001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180310001.